Hippo signalling: Liver size regulation and beyond

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 5, 2011, Pages 344-346

  Tordjmann, T ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN HIPPO; PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; HOMEOSTASIS; HUMAN; LIVER CARCINOGENESIS; LIVER SIZE; NONHUMAN; ORGANOGENESIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LIVER; LIVER NEOPLASMS; ORGAN SIZE; PROTEIN KINASES;

EID: 79956346081     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.01.012     Document Type: Article

References (16)

1. Conlon I., Raff M. Size control in animal development. Cell 1999, 96:235-244.
2. Fausto N., Campbell J.S., Riehle K.J. Liver regeneration. Hepatology 2006, 43:S45-S53.
3. Pan D. Hippo signalling in organ size control. Genes Dev 2007, 21:886-897.
4. Pan D. The hippo signalling pathway in development and cancer. Dev Cell 2010, 19:491-505.
5. Zhang L., Ren F., Zhang Q., Chen Y., Wang B., Jiang J. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signalling in organ size control. Dev Cell 2008, 14:377-387.
6. Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007, 21:2747-2761.
7. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
8. Zhang N., Bai H., David K.K., Dong J., Zheng Y., Cai J., et al. The Merlin/NF2 tumour suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010, 19:27-38.
9. Zhou D., Conrad C., Xia F., Park J.S., Payer B., Yin Y., et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009, 16:425-438.
10. Xu M.Z., Yao T.J., Lee N.P., Ng I.O., Chan Y.T., Zender L., et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009, 115:4576-4585.
11. Song H., Mak K.K., Topol L., Yun K., Hu J., Garrett L., et al. Mammalian Mst1 Mst2 kinases play essential roles in organ size control tumor suppression. Proc Natl Acad Sci U S A 2010, 107:1431-1436.
12. Lu L., Li Y., Kim S.M., Bossuyt W., Liu P., Qiu Q., et al. Hippo signalling is a potent in vivo growth tumour suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 2010, 107:1437-1442.
13. Lee K.P., Lee J.H., Kim T.S., Kim T.H., Park H.D., Byun J.S., et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation liver size, liver tumorigenesis. Proc Natl Acad Sci U S A 2010, 107:8248-8253.
14. Benhamouche S., Curto M., Saotome I., Gladden A.B., Liu C.H., Giovannini M., et al. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev 2010, 24:1718-1730.
15. Yi C., Kissil J.L. Merlin in organ size control and tumorigenesis: Hippo versus EGFR?. Genes Dev 2010, 24:1673-1679.
16. Cai J., Zhang N., Zheng Y., de Wilde R.F., Maitra A., Pan D. The Hippo signalling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 2010, 24:2383-2388.